The Italian registry of myelofibrosis is one year old

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Leukemia·2016

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Leukemia·2016

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Leukemia·2015

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Leukemia·2015

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Leukemia·2014

Response to Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Haematologica·2026

Salvage of primary graft failure with allogeneic hematopoietic stem cell transplantation from a deceased organ donor: report of a novel graft source.

Haematologica·2026

Philadelphia chromosome-like acute lymphoblastic leukemia: treat intensively, transplant selectively.

Haematologica·2026

The role of CHIP and pre-treatment neutropenia in patients treated with chimeric antigen receptor T cells for hematological malignancies.

Haematologica·2026

Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib.

Haematologica·2026

CD25-based graft-versus-host disease prophylaxis after haploidentical hematopoietic stem cell transplantation: comparison of two prophylactic strategies.

Haematologica·2026

Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil.

Journal of human immunity·2026

A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.

Journal of virology·2026

The lactate dehydrogenase-to-albumin ratio is independently associated with moderate-to-severe tubulointerstitial fibrosis in patients with IgA nephropathy.

Frontiers in nephrology·2026

Staphylococcus aureus in bovine intramammary infections: A global systematic review and meta-analysis of prevalence and antimicrobial resistance patterns.

New microbes and new infections·2026

Development and evaluation of a dual-target glycoconjugate against Shigella sonnei.

Frontiers in immunology·2026

SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.

Journal of microbiology and biotechnology·2026

Related Experiment Videos

The Italian registry of myelofibrosis is one year old

Related Concept Videos

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT).

Response to Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Salvage of primary graft failure with allogeneic hematopoietic stem cell transplantation from a deceased organ donor: report of a novel graft source.

Philadelphia chromosome-like acute lymphoblastic leukemia: treat intensively, transplant selectively.

The role of CHIP and pre-treatment neutropenia in patients treated with chimeric antigen receptor T cells for hematological malignancies.

Measurable residual disease-negative remission of BRAF-V600Emutated acute myeloid leukemia with dabrafenib and trametinib.

CD25-based graft-versus-host disease prophylaxis after haploidentical hematopoietic stem cell transplantation: comparison of two prophylactic strategies.

Autoantibodies neutralizing type I interferons in COVID-19 patients from southern Brazil.

A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.

The lactate dehydrogenase-to-albumin ratio is independently associated with moderate-to-severe tubulointerstitial fibrosis in patients with IgA nephropathy.

Staphylococcus aureus in bovine intramammary infections: A global systematic review and meta-analysis of prevalence and antimicrobial resistance patterns.

Development and evaluation of a dual-target glycoconjugate against Shigella sonnei.

SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.

Related Experiment Videos

The Italian registry of myelofibrosis is one year old

Related Concept Videos

Related Articles